Physician profile

Bryan Wellman

Neurological Surgery · Rapid City, SD

NPI 1891776456

$3,693.19

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$135.66

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Globus Medical, INC. $1,613.44 2019-2022
Ge Healthcare $1,305.84 2019
Wenzel Spine, INC. $356.85 2019-2023 Varilift
Kuros Biosciences USA, INC $193.62 2021
Relievant Medsystems, INC. $73.33 2022
Orthofix Medical, INC. $60.58 2020
Nevro Corp. $57.44 2022
Medical Device Business Services, INC. $32.09 2023 Spine & Trauma 3d Navigation

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bryan Wellman

$3,693.19

in general payments reported 2019-2025

Years
2019-2023
Top company
Globus Medical, INC.

https://glasscript.com/doctor/358695/bryan-wellman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.